NIMESID Tablet is an effective analgesic and anti-inflammatory medication developed to manage pain, inflammation, and fever across a wide range of medical conditions. Each tablet contains Nimesulide, a selective COX-2 inhibitor that helps block the production of prostaglandins responsible for inflammation and pain response. NIMESID offers quick relief with a favorable safety profile when used appropriately and for short durations.
The formulation is particularly effective in managing acute inflammatory conditions such as joint pain, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-operative pain, and menstrual cramps. Its pharmacodynamic action provides both symptomatic and therapeutic benefits, reducing inflammation at the site of pain while also lowering body temperature when fever is present.
Manufactured by Bluepill Express, NIMESID Tablet is produced in state-of-the-art WHO-GMP-compliant facilities, ensuring consistent quality and adherence to international regulatory requirements. From sourcing of raw materials to final packaging, each step in the manufacturing process is closely monitored to ensure that the finished product meets global standards.
NIMESID Tablet acts quickly—often within 30 minutes—providing rapid pain relief and increased comfort for patients. Its action is more targeted compared to traditional NSAIDs, reducing the risk of gastrointestinal side effects associated with non-selective COX inhibition. However, like all NSAIDs, it should be taken with caution in individuals with a history of gastric ulcers, liver impairment, or NSAID hypersensitivity.
Bluepill Express offers NIMESID in tamper-proof blister packaging for retail distribution and in export-optimized formats for bulk or institutional sales. The tablet is film-coated to improve swallowability and reduce gastric discomfort. All batches undergo strict quality testing including dissolution profile analysis, microbial testing, and stability testing across various climatic zones.
As a trusted third-party manufacturer and exporter, Bluepill Express provides all supporting technical documents including Certificate of Analysis (COA), Product Dossiers, MSDS, and marketing authorization support upon request. Private labeling options are also available to meet branding needs of global partners.
NIMESID Tablet is recommended for adult patients and should be prescribed for short-term use under medical supervision. Long-term or unsupervised usage is discouraged due to potential hepatotoxicity, a known risk associated with prolonged use of Nimesulide. The product is not recommended for children under 12 years, pregnant or lactating women, or individuals with known hepatic conditions.
Description provided by Bluepill Express.
Nimesulide, a selective COX-2 inhibitor
Relief from pain, inflammation, and fever due to musculoskeletal disorders, arthritis, dental pain, dysmenorrhea, post-operative pain
Typically within 30 minutes
Film-coated tablet for improved swallowability and reduced gastric irritation
Produced under WHO-GMP compliant facilities by Bluepill Express
Tamper-proof blister packs for retail and export-optimized bulk packaging
Selective COX-2 inhibition reduces gastrointestinal side effects compared to traditional NSAIDs
Rigorous dissolution, microbial, and stability testing; supported by COA, MSDS, and product dossier
Short-term use under medical supervision; not recommended for children under 12, pregnant or lactating women, or those with liver impairment
Available for global business partners
Specifications
Strength
Typically 100 mg Nimesulide per tablet (specific strength can be provided upon request)
Color and Shape
Film-coated, round/oval (refer to packaging)
Shelf Life
Typically 24 months under recommended storage conditions
Storage Conditions
Store in a cool, dry place away from direct sunlight
Expiry
As per packaging batch
Therapeutic Category
NSAID - selective COX-2 inhibitor
Manufacturing Location
Bluepill Express’s WHO-GMP certified plant
Packaging Details
Blister packs (strip sizes available on demand); bulk packaging for institutional orders
Regulatory Compliance
Compliant with international pharmaceutical manufacturing and export standards